Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV vaccines: a global perspective.

J Esparza1, S Osmanov

  • 1WHO-UNAIDS HIV Vaccine Initiative, World Health Organization, Geneva, Switzerland. esparzaj@who.int

Current Molecular Medicine
|April 18, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Treatment of adolescent varicocele: is percutaneous embolization better?].

Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica·2009
Same author

Purely intramedullary spinal cord primitive neuroectodermal tumor: case report and review of the literature.

Neurocirugia (Asturias, Spain)·2009
Same author

Recurrent meningitis and persistence of craniopharyngeal canal: case report.

Neurocirugia (Asturias, Spain)·2009
Same author

Surgical treatment of isolated and syndromic craniosynostosis. Results and complications in 283 consecutive cases.

Neurocirugia (Asturias, Spain)·2008
Same author

[Radiation exposure in children undergoing diagnostic imaging: a study of Pamplona County].

Radiologia·2008
Same author

[Positional plagiocephaly. Diagnosis and treatment].

Neurocirugia (Asturias, Spain)·2007
Same journal

Corrigendum to: Sortilin as a Culprit in the Atherosclerosis Plaque Progression: Evidence from Clinical and Experimental Studies.

Current molecular medicine·2026
Same journal

Dynamic Expression of Fibroblast Activation Protein (FAP) During Chronic Pancreatitis (CP) Progression in Mice and Evaluation of FAP-targeted Tracers for Early CP Diagnosis.

Current molecular medicine·2026
Same journal

Causal Relationship Between 91 Inflammatory Factors and Gastritis: A Two-Sample Bidirectional Mendelian Randomization Study.

Current molecular medicine·2026
Same journal

Therapeutic Potential of Pistacia Atlantica Gum in Aspirin-Induced Peptic Ulcers: A Dose-Dependent Approach to Mucosal Protection and Hepatorenal Safety.

Current molecular medicine·2026
Same journal

Identification and Characterization of MicroRNAs Associated with Borax-mediated Anti-tumor Activity through High-throughput Technology.

Current molecular medicine·2026
Same journal

Broad-Spectrum Vaccines: Challenges and Opportunities (A Systematic Review).

Current molecular medicine·2026
See all related articles

Developing an effective HIV vaccine faces challenges like understanding immune responses and viral diversity. Over 70 trials have occurred globally, with ongoing research focusing on combined immune strategies for better vaccine efficacy.

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Diseases

Background:

  • Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) is a major global health crisis, particularly in Africa.
  • A preventive vaccine is crucial for long-term HIV/AIDS control.
  • Vaccine development faces hurdles including understanding immune correlates of protection, primate model relevance, and HIV strain variability.

Purpose of the Study:

  • To review the progress and challenges in HIV vaccine development.
  • To highlight the evolution of HIV vaccine research paradigms.
  • To emphasize the need for planning equitable access to future vaccines.

Main Methods:

  • Overview of over 70 phase I/II clinical trials conducted globally since 1987.
  • Analysis of the progression of HIV vaccine candidate strategies.

Related Experiment Videos

  • Examination of trials conducted in industrialized and developing countries.

    • Main Results:

    • Over 30 candidate vaccines have been tested in clinical trials.
    • HIV vaccine trials have expanded to developing countries, including Africa, Latin America, and the Caribbean.
    • Current research focuses on optimizing both humoral and cell-mediated immune responses.

    Conclusions:

    • Despite significant challenges, HIV vaccine research has progressed through multiple developmental waves.
    • First-generation vaccine efficacy trials are yielding results, informing future development.
    • Proactive planning is essential to ensure widespread access to effective HIV vaccines.